4 completed, 2 terminated, 1 unknown, 1 withdrawn. 8 Phase 1, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 4, Terminated 2, Unknown 1, Withdrawn 1 |
| Phase 2 | 6 | Completed 2, Terminated 2, Unknown 1, Withdrawn 1 |
Follow Uveitis, Posterior: new trials by email Literature Review of Uveitis, Posterior trials Research Report on Uveitis, Posterior
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Preliminary Efficacy Study of V404 PDS in Uveitis V404 - Uveitis, Posterior, Uveitis, Intermediate | Phase 1 / Phase 2 | Terminated | Forsight Vision4 | 7 | 2014-04-01 | 2016-12-09 |
| Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study Tocilizumab - Intermediate Uveitis, Posterior Uveitis | Phase 1 / Phase 2 | Unknown | University of Nebraska | 36 | 2013-03-01 | 2017-04-28 |
| Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis triamcinolone acetonide (Triesence®) - Uveitis, Intermediate Uveitis | Phase 1 / Phase 2 | Completed | Clearside Biomedical, Inc. | 11 | 2013-02-01 | 2021-02-21 |
| Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study Intravitreal Infliximab - Behçet's Disease, Uveitis | Phase 1 / Phase 2 | Completed | Cairo University | 20 | 2013-01-01 | 2015-12-03 |
| Treatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate Methotrexate - Non-infectious Intermediate and Posterior Uveitis | Phase 1 / Phase 2 | Terminated | National Eye Institute (NEI) | 2 | 2011-02-01 | 2019-03-27 |
| Sirolimus as Therapeutic Approach to Uveitis Sirolimus (rapamycin) - Uveitis, Intermediate Uveitis | Phase 1 | Completed | Johns Hopkins University | 30 | 2009-07-01 | 2018-08-20 |
| A Phase I/IIa Study for the Treatment of Uveitis With Iontophoresis Iontophoresis second generation Eyegate II device - Uveitis | Phase 1 / Phase 2 | Withdrawn | Asociación para Evitar la Ceguera en México | 2007-09-01 | 2024-05-30 | |
| Prophylactic Anecortave Acetate in Patients With a Retisert Implant anecortave acetate - Uveitis, Posterior, Glaucoma | Phase 1 | Completed | Texas Retina Associates | 12 | 2006-09-01 | 2012-06-05 |
Uveitis (6) · Uveitis, Intermediate (5) · Panuveitis (3) · Behcet Syndrome (1) · Choroidal Effusions (1) · Giant Cell Arteritis (1) · Glaucoma (1) · Inflammation (1) · Macular Edema (1) · Ophthalmia, Sympathetic (1) · Uveitis, Anterior (1)
Eye Diseases (8) · Uveal Diseases (8) · Panuveitis (5) · Cardiovascular Diseases (2) · Skin Diseases (2) · Skin Diseases, Vascular (2) · Skin and Connective Tissue Diseases (2) · Uveitis (2) · Vascular Diseases (2) · Vasculitis (2) · Arteritis (1) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Brain Diseases (1) · Central Nervous System Diseases (1)
Methotrexate (2) · Adrenal Cortex Hormones (1) · Sirolimus (1) · Triamcinolone (1) · Triamcinolone Acetonide (1) · anecortave acetate (1) · tocilizumab (1)
Asociación para Evitar la Ceguera en México (1) · Cairo University (1) · Clearside Biomedical, Inc. (1) · Forsight Vision4 (1) · Johns Hopkins University (1) · National Eye Institute (NEI) (1) · Texas Retina Associates (1) · University of Nebraska (1)
United States (6) · Mexico (1)
Quan D Nguyen, MD, MSc (2) · David G Callanan, MD (1) · Hatice N Sen, M.D. (1) · Hugo Quiroz-Mercado, MD (1) · Lourdes Arellanes, MD (1) · Mahmoud Soliman, MD PhD (1) · Raul Velez-Montoya, MD (1) · Thomas Ciulla, MD (1)